Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Dimic Janjic (Beograd, Republic of Serbia), B. Milenkovic (Beograd, Republic of Serbia), M. Stjepanovic (Beograd, Republic of Serbia), J. Jankovic (Beograd, Republic of Serbia), J. Cvejic (Beograd, Republic of Serbia), I. Milivojevic (Beograd, Republic of Serbia). Correlation of serum Matrix metalloproteinase-9 and clinico-functional parameters in COPD patients. 3312

Member's Comments

No comment yet.

Related content which might interest you: Increased concentration of matrix metalloproteinase-9 in serum of COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 54s Year: 2005 Matrix metalloproteinase-9 (MMP-9) elevated in serum, but not in bronchial lavage in lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 328s Year: 2005 Sputum matrix metalloproteinase-9 and tissue inhibitor of matrix metalloprotienase-1 levels in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 651s Year: 2006 Matrix metalloproteinase (MMP) 12 is associated with clinical parameters of disease severity and exacerbations in asthma Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010 Matrix metalloproteinase levels of bronchial mucosa and the correlation with clinical parameters in clinically stable bronchiectasis Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients Source: Eur Respir J 2005; 25: 885-890 Year: 2005 Matrix metalloproteinases, as markers of the severity of idiopathic pulmonary fibrosis Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Expression of matrix metalloproteinases and TIMP inhibitors in circulation/lung in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 Effect of theophylline on matrix metalloproteinase-9 in induced sputum in the elderly patients with asthma Source: Eur Respir J 2003; 22: Suppl. 45, 107s Year: 2003 Circulating matrix metalloproteinase-9 (MMP-9) is associated with the extension of lung disease in patients with active tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 35s Year: 2004 The influence of steroidotherapy in COPD exacerbation on matrix metalloproteinase MMP-9 level in BAL, induced sputum and serum Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004 Relationship between circulating serpina 3g, activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, 2 with chronic obstructive pulmonary disease severity Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Could concentration of matrix metalloproteinase-9 in serum of COPD patients change into the basic disease progress and a degree of airway obstruction? Source: Eur Respir J 2006; 28: Suppl. 50, 37s Year: 2006 Correlation between matrix metalloproteinase-9 serum levels and disease severity in pulmonary tuberculosis patients Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016 Matrix metalloproteinase (MMP) 12 is not associated with clinical parameters of severity in cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010 Relationship between the Matrix Metalloproteinases (MMPs) levels and lung mechanic parameters established by impulse oscillometry (IOS) in patients with pulmonary tuberculosis (TB) Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 Matrix metalloproteinase, hyaluronic acid and C-reactive protein: Are they really markers of lung obstruction at COPD but not cardiovascular comorbidity? Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 The role of matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMMP-1) in sarcoidosis and idiopathic pulmonary fibrosis. Correlation with echocardiography Source: Eur Respir J 2006; 28: Suppl. 50, 745s Year: 2006 Are there serum levels of MMP-2 and MMP-9 may be markers of COPD phenotypes? Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Matrix metalloproteinase (MMP) 9 is associated with clinical parameters of severity in cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010